Skip to content
October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Rise and Revitalize: The Science and Practice of a 15-Minute Morning Yoga Flow rise-and-revitalize-the-science-and-practice-of-a-15-minute-morning-yoga-flow
  • Integrative Oncology and Holistic Care

Rise and Revitalize: The Science and Practice of a 15-Minute Morning Yoga Flow

Raul Delapena Setiawan August 20, 2026
Published August 20, 2026 For many, the transition from the REM-induced stillness of sleep to the high-velocity...
Read More Read more about Rise and Revitalize: The Science and Practice of a 15-Minute Morning Yoga Flow
Ibuprofen: Beyond Pain Relief – Unveiling its Unexpected Anti-Cancer Potential ibuprofen-beyond-pain-relief-unveiling-its-unexpected-anti-cancer-potential-1
  • Medical Research and Clinical Trials

Ibuprofen: Beyond Pain Relief – Unveiling its Unexpected Anti-Cancer Potential

Rifan Muazin August 20, 2026
Main Facts Ibuprofen, a ubiquitous over-the-counter medication renowned for its efficacy in alleviating pain and inflammation, is...
Read More Read more about Ibuprofen: Beyond Pain Relief – Unveiling its Unexpected Anti-Cancer Potential
The Pharmaceutical AI Arms Race: Bristol Myers Squibb Stakes Claim to Industry’s Most Powerful Supercomputer the-pharmaceutical-ai-arms-race-bristol-myers-squibb-stakes-claim-to-industrys-most-powerful-supercomputer
  • Treatment Innovations

The Pharmaceutical AI Arms Race: Bristol Myers Squibb Stakes Claim to Industry’s Most Powerful Supercomputer

Rifan Muazin August 20, 2026
The pharmaceutical industry is currently witnessing an unprecedented escalation in digital capability. On Monday, Bristol Myers Squibb...
Read More Read more about The Pharmaceutical AI Arms Race: Bristol Myers Squibb Stakes Claim to Industry’s Most Powerful Supercomputer
Advancing Colorectal Precision: Colospan Achieves Breakthrough in Intraoperative Tissue Assessment advancing-colorectal-precision-colospan-achieves-breakthrough-in-intraoperative-tissue-assessment
  • Treatment Innovations

Advancing Colorectal Precision: Colospan Achieves Breakthrough in Intraoperative Tissue Assessment

Nila Kartika Wati August 20, 2026
In a significant milestone for colorectal surgery, Colospan—a wholly owned subsidiary of Galmed Pharmaceuticals—has announced the successful...
Read More Read more about Advancing Colorectal Precision: Colospan Achieves Breakthrough in Intraoperative Tissue Assessment
A New Era for Preventive Medicine: Breast Cancer Canada Applauds Federal Advisory Committee Launch a-new-era-for-preventive-medicine-breast-cancer-canada-applauds-federal-advisory-committee-launch
  • Global Breast Cancer Awareness

A New Era for Preventive Medicine: Breast Cancer Canada Applauds Federal Advisory Committee Launch

Ammar Sabilarrohman August 20, 2026
OTTAWA – In a significant move aimed at modernizing Canada’s healthcare framework, the federal government has officially...
Read More Read more about A New Era for Preventive Medicine: Breast Cancer Canada Applauds Federal Advisory Committee Launch
A Beacon of Hope: Shelly’s Journey Through Breast Cancer, Guided by Compassion and Support a-beacon-of-hope-shellys-journey-through-breast-cancer-guided-by-compassion-and-support
  • Patient Advocacy and Support

A Beacon of Hope: Shelly’s Journey Through Breast Cancer, Guided by Compassion and Support

Lina Hope August 20, 2026
February 3, 2026 – The word "cancer" can strike fear into the hearts of even the most...
Read More Read more about A Beacon of Hope: Shelly’s Journey Through Breast Cancer, Guided by Compassion and Support
UK Clinical Trial Reforms Show Promising Early Results, Aiming to Rekindle Global Competitiveness uk-clinical-trial-reforms-show-promising-early-results-aiming-to-rekindle-global-competitiveness
  • Medical Research and Clinical Trials

UK Clinical Trial Reforms Show Promising Early Results, Aiming to Rekindle Global Competitiveness

Muslim August 20, 2026
London, UK – [Date] – A significant overhaul of the United Kingdom’s clinical trial regulatory landscape is...
Read More Read more about UK Clinical Trial Reforms Show Promising Early Results, Aiming to Rekindle Global Competitiveness
The Copper Connection: Pioneering New Research into Triple-Negative Breast Cancer the-copper-connection-pioneering-new-research-into-triple-negative-breast-cancer
  • Clinical Oncology Education

The Copper Connection: Pioneering New Research into Triple-Negative Breast Cancer

Pevita Pearce August 20, 2026
In the landscape of oncology, few diagnoses carry the weight of "triple-negative breast cancer" (TNBC). Characterized by...
Read More Read more about The Copper Connection: Pioneering New Research into Triple-Negative Breast Cancer
A Paradigm Shift in HIV Care: Gilead and Merck’s Once-Weekly Regimen Poised to Disrupt the Market a-paradigm-shift-in-hiv-care-gilead-and-mercks-once-weekly-regimen-poised-to-disrupt-the-market
  • Chemotherapy and Targeted Therapy

A Paradigm Shift in HIV Care: Gilead and Merck’s Once-Weekly Regimen Poised to Disrupt the Market

Laily UPN August 20, 2026
The landscape of HIV treatment is on the precipice of a significant transformation. At the 26th International...
Read More Read more about A Paradigm Shift in HIV Care: Gilead and Merck’s Once-Weekly Regimen Poised to Disrupt the Market
Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes groundbreaking-research-reveals-age-related-blood-cell-mutations-infiltrate-tumours-worsening-cancer-outcomes-1
  • Medical Research and Clinical Trials

Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Layla Zulfa August 20, 2026
London, UK – [Insert Date] – In a significant advance for cancer research, an international consortium of...
Read More Read more about Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Posts pagination

Previous 1 … 364 365 366 367 368 369 370 … 835 Next

Recent Posts

  • Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors
  • Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial
  • Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment
  • Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress
  • Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-the-silent-threat-groundbreaking-st-jude-research-reveals-genetic-blueprint-of-secondary-cancers-in-childhood-survivors
  • Medical Research and Clinical Trials

Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors

Layla Zulfa October 29, 2026
eli-lillys-retatrutide-surges-ahead-in-weight-loss-race-outperforming-novo-nordisks-ozempic-in-landmark-trial
  • Medical Research and Clinical Trials

Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial

Ammar Sabilarrohman October 29, 2026
reclaiming-intimacy-navigating-sexual-health-after-breast-cancer-treatment
  • Patient Advocacy and Support

Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment

Basiran October 29, 2026
Scientists working with samples in laboratory
  • Patient Advocacy and Support

Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress

Azzam Bilal Chamdy October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.